ロード中...
Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis
BACKGROUND: The most common cystic fibrosis (CF) manifestation is the progressive chronic obstructive pulmonary disease caused by deficiency, dysfunction, or absence of the CFTR (Cystic Fibrosis Transmembrane Regulator) protein on the apical surface of the cells in the respiratory tract. The use of...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3558405/ https://ncbi.nlm.nih.gov/pubmed/22950544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-12-50 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|